Compounds > n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide
Page last updated: 2024-09-03

n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and 5,7-dihydroxytryptamine

n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide has been researched along with 5,7-dihydroxytryptamine in 1 studies

Compound Research Comparison

Studies
(n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide)		Trials
(n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide)		Recent Studies (post-2010)
(n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide)		Studies
(5,7-dihydroxytryptamine)		Trials
(5,7-dihydroxytryptamine)		Recent Studies (post-2010) (5,7-dihydroxytryptamine)
730301,278055

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chopde, CT; Deshpande, LS; Khisti, RT1

Other Studies

1 other study(ies) available for n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and 5,7-dihydroxytryptamine

ArticleYear
Cataleptic effect of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice: modulation by serotonergic agents.
    Brain research, 2001, Apr-13, Volume: 898, Issue:1

    Topics: 5,7-Dihydroxytryptamine; Animals; Bicuculline; Catalepsy; Drug Synergism; Enzyme Inhibitors; GABA Antagonists; Indoleacetic Acids; Indomethacin; Male; Mice; Pregnanolone; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Synaptic Transmission

2001